Cardiac effects of CPAP treatment in patients with obstructive sleep apnea and atrial fibrillation
- 27 Downloads
Obstructive sleep apnea (OSA) has been recognized as an independent risk factor for the development and progression of atrial fibrillation (AF). We aimed to investigate the changes in heart rate and atrial and ventricular ectopy after continuous positive airway pressure (CPAP) treatment in patients with OSA and AF.
Consecutive patients with AF underwent ambulatory sleep monitoring, and OSA was defined as an Apnea-Hypopnea-Index (AHI) ≥ 5/h. Treated patients completed in-laboratory CPAP titration study. A 24-h ECG Holter was performed at baseline and at 3 and 6 months after CPAP treatment.
One hundred patients (70% males) with AF were included in the final analysis. OSA was diagnosed in 85% of patients. There were no significant changes in mean 24-h heart rate in patients with paroxysmal or permanent AF at 3 and 6 months of treatment compared to baseline. In patients with paroxysmal AF (n = 29), atrial and ventricular ectopy counts/24 h significantly decreased at 3 months compared to baseline (median (IQR) 351 (2049) to 57 (182), P = 0.002; 68 (105) to 16 (133), P = 0.01 respectively). At 6 months follow-up, the atrial ectopy count/24 h significantly decreased in patients with paroxysmal AF compared to baseline (median (IQR) 351 (2049) to 31 (113), P = 0.016, n = 14). In patients with permanent AF (n = 15), there was a significant reduction in ventricular ectopy count/24 h at 3 months compared to baseline (median (IQR) 100 (1116) to 33 (418), P = 0.02).
There is a significant decrease in atrial and ventricular ectopy count/24 h in patients with AF and OSA at 3 and 6 months of CPAP treatment compared to baseline.
KeywordsObstructive sleep apnea Atrial fibrillation Continuous positive airway pressure Atrial ectopy Ventricular ectopy CPAP compliance Arrhythmia Ambulatory sleep monitoring
Continuous positive airway pressure
Obstructive sleep apnea
Total sleep time
We appreciate the collaboration and administrative support of the staff at the Sleep and Alertness Clinic, the Cardiomatters Diagnostics, and the Atrial Fibrillation Clinic at St. Michael’s Hospital in Toronto, ON, Canada. We acknowledge the support of the Neurozone MSH Inc. Canada and the CPAP Direct Ltd.
The Neurozone MSH Inc. Canada provided the equipment of home sleep testing for participants in the study. CPAP devices and supplies were provided by the CPAP Direct Ltd.
Compliance with ethical standards
Ethical approval was obtained from University Health Network and St. Michael’s Hospital Research Ethics Boards.
Conflict of interest
CS has shares in the Neurozone MSH Inc. Canada which provided the equipment for the ambulatory sleep testing and the analysis of the sleep reports testing system. AA, DN, and PD have no conflicts of interest to disclose.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
- 3.Abumuamar AM, Mollayeva T, Sandor P, Newman D, Nanthakumar K, Shapiro CM. Efficacy of continuous positive airway pressure treatment in patients with cardiac arrhythmia and obstructive sleep apnea: what is the evidence? Clinical Medicine Insights: Therapeutics. 2017;9(Supplementary Material_734227):1179559X17734227. https://doi.org/10.1177/1179559X17734227.CrossRefGoogle Scholar
- 10.Orban M, Bruce CJ, Pressman GS, Leinveber P, Romero-Corral A, Korinek J, et al. Dynamic changes of left ventricular performance and left atrial volume induced by the mueller maneuver in healthy young adults and implications for obstructive sleep apnea, atrial fibrillation, and heart failure. Am J Cardiol. 2008;102(11):1557–61. https://doi.org/10.1016/j.amjcard.2008.07.050.CrossRefPubMedPubMedCentralGoogle Scholar
- 11.Mazza A, Bendini MG, Cristofori M, Nardi S, Leggio M, De Cristofaro R, et al. Baseline apnoea/hypopnoea index and high-sensitivity C-reactive protein for the risk of recurrence of atrial fibrillation after successful electrical cardioversion: a predictive model based upon the multiple effects of significant variables. Europace. 2009;11(7):902–9. https://doi.org/10.1093/europace/eup107.CrossRefPubMedGoogle Scholar
- 13.Mills PJ, Kennedy BP, Loredo JS, Dimsdale JE, Ziegler MG. Effects of nasal continuous positive airway pressure and oxygen supplementation on norepinephrine kinetics and cardiovascular responses in obstructive sleep apnea. Europace. 2006;100(1):343–8. https://doi.org/10.1152/japplphysiol.00494.2005.CrossRefGoogle Scholar
- 15.Bayir PT, Demirkan B, Bayir O, Duyuler S, Firat H, Güray U, et al. Impact of continuous positive airway pressure therapy on atrial electromechanical delay and P-wave dispersion in patients with obstructive sleep apnea. Ann Noninvasive Electrocardiol. 2014;19(3):226–33. https://doi.org/10.1111/anec.12106.CrossRefPubMedGoogle Scholar
- 17.A comparison of two nights of ambulatory sleep testing in arrhythmia patients. - PubMed - NCBI. (n.d.). Retrieved August 1, 2018, from https://www.ncbi.nlm.nih.gov/pubmed/29973998
- 19.Holmqvist F, Guan N, Zhu Z, Kowey PR, Allen LA, Fonarow GC, et al. Impact of obstructive sleep apnea and continuous positive airway pressure therapy on outcomes in patients with atrial fibrillation—results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF). Am Heart J. 2015;169(5):647–654.e2. https://doi.org/10.1016/j.ahj.2014.12.024.CrossRefPubMedGoogle Scholar
- 20.Kanagala R, Murali NS, Friedman PA, Ammash NM, Gersh BJ, Ballman KV, et al. Obstructive sleep apnea and the recurrence of atrial fibrillation. Circulation. 2003;107(20):2589–94. https://doi.org/10.1161/01.CIR.0000068337.25994.21.CrossRefPubMedGoogle Scholar
- 26.Schlatzer C, Schwarz EI, Sievi NA, Clarenbach CF, Gaisl T, Haegeli LM, et al. Intrathoracic pressure swings induced by simulated obstructive sleep apnoea promote arrhythmias in paroxysmal atrial fibrillation. Europace. 2016;18(1):64–70. https://doi.org/10.1093/europace/euv122.CrossRefPubMedGoogle Scholar
- 28.Serizawa N, Yumino D, Kajimoto K, Tagawa Y, Takagi A, Shoda M, et al. Impact of sleep-disordered breathing on life-threatening ventricular arrhythmia in heart failure patients with implantable cardioverter-defibrillator. Am J Cardiol. 2008;102(8):1064–8. https://doi.org/10.1016/j.amjcard.2008.05.057.CrossRefPubMedGoogle Scholar
- 29.Kwon Y, Koene RJ, Kwon O, Kealhofer JV, Adabag S, Duval S. Effect of sleep-disordered breathing on appropriate implantable cardioverter-defibrillator therapy in patients with heart failure: a systematic review and meta-analysis. Circ Arrhythm Electrophysiol. 2017;10(2):–e004609. https://doi.org/10.1161/CIRCEP.116.004609.